# A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer

> **NCT00218205** · PHASE2 · UNKNOWN · sponsor: **Department of Veterans Affairs, New Jersey** · enrollment: 28 (—)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Epirubicin
- **DRUG:** Estramustine Phosphate
- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT00218205
- **Lead sponsor:** Department of Veterans Affairs, New Jersey
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 28 (—)
- **Last updated:** 2005-09-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00218205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00218205, "A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00218205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*